Stephane Bancel - Net Worth and Insider Trading
Stephane Bancel Net Worth
The estimated net worth of Stephane Bancel is at least $2.7 Billion dollars as of 2023-05-31. Stephane Bancel is the CEO of Moderna Inc and owns about 21,027,198 shares of Moderna Inc (MRNA) stock worth over $2.7 Billion. Details can be seen in Stephane Bancel's Latest Holdings Summary section.
Transaction Summary of Stephane Bancel
Stephane Bancel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephane Bancel owns 3 companies in total, including Moderna Inc (MRNA) , Syros Pharmaceuticals Inc (SYRS) , and BG Medicine Inc (BGMD) .
Click here to see the complete history of Stephane Bancel’s form 4 insider trades.
Insider Ownership Summary of Stephane Bancel
|Ticker||Comapny||Transaction Date||Type of Owner|
|MRNA||Moderna Inc||2018-12-07||director & Chief Executive Officer|
|SYRS||Syros Pharmaceuticals Inc||2016-06-29||director|
|BGMD||BG Medicine Inc||2014-06-03||director|
Stephane Bancel Latest Holdings Summary
Stephane Bancel currently owns a total of 1 stock. Stephane Bancel owns 21,027,198 shares of Moderna Inc (MRNA) as of May 25, 2023, with a value of $2.7 Billion.
Latest Holdings of Stephane Bancel
|Ticker||Comapny||Latest Transaction Date||Shares Owned||Current Price ($)||Current Value ($)|
Holding Weightings of Stephane Bancel
Stephane Bancel Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephane Bancel has made a total of 245 transactions in Moderna Inc (MRNA) over the past 5 years, including 0 buys and 245 sells. The most-recent trade in Moderna Inc is the sale of 80,000 shares on May 25, 2023, which brought Stephane Bancel around $10 Million.
Insider Trading History of Stephane Bancel
Stephane Bancel Trading Performance
Stephane Bancel Ownership Network
Ownership Network List of Stephane Bancel
Ownership Network Relation of Stephane Bancel
Stephane Bancel Owned Company Details
What does Moderna Inc do?
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Who are the key executives at Moderna Inc?
Stephane Bancel is the director & Chief Executive Officer of Moderna Inc. Other key executives at Moderna Inc include Chief Financial Officer James M Mock , Chief Commercial Officer Arpa Garay , and See Remarks Jorge M Gomez .
Moderna Inc (MRNA) Insider Trades Summary
Over the past 18 months, Stephane Bancel made 77 insider transaction in Moderna Inc (MRNA) with a net sale of 4,757,000. Other recent insider transactions involving Moderna Inc (MRNA) include a net sale of 161,761 shares made by Juan Andres , a net sale of 710,000 shares made by Noubar Afeyan , and a net sale of 388,317 shares made by Stephen Hoge .
In summary, during the past 3 months, insiders sold 960,811 shares of Moderna Inc (MRNA) in total and bought 0 shares, with a net sale of 960,811 shares. During the past 18 months, 6,020,603 shares of Moderna Inc (MRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,020,603 shares.
Moderna Inc (MRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Moderna Inc Insider Transactions
Stephane Bancel Mailing Address
Above is the net worth, insider trading, and ownership report for Stephane Bancel. You might contact Stephane Bancel via mailing address: 320 Bent Street, Cambridge Ma 02141.